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Tumour necrosis factor alpha
Lipopolysaccharidea b s t r a c t
Seasonal animals undergo changes in physiology and behavior between summer and winter conditions.
These changes are in part driven by a switch in a series of hypothalamic genes under transcriptional con-
trol by hormones and, of recent interest, inflammatory factors. Crucial to the control of transcription are
histone deacetylases (HDACs), generally acting to repress transcription by local histone modification.
Seasonal changes in hypothalamic HDAC transcripts were investigated in photoperiod-sensitive F344 rats
by altering the day-length (photoperiod). HDAC4, 6 and 9 were found to change in expression. The poten-
tial influence of HDACs on two hypothalamic signaling pathways that regulate transcription, inflamma-
tory and nuclear receptor signaling, was investigated. For inflammatory signaling the focus was on NF-jB
because of the novel finding made that its expression is seasonally regulated in the rat hypothalamus. For
nuclear receptor signaling it was discovered that expression of retinoic acid receptor beta was regulated
seasonally. HDAC modulation of NF-jB-induced pathways was examined in a hypothalamic neuronal cell
line and primary hypothalamic tanycytes. HDAC4/5/6 inhibition altered the control of gene expression
(Fos, Prkca, Prkcd and Ptp1b) by inducers of NF-jB that activate inflammation. These inhibitors also mod-
ified the action of nuclear receptor ligands thyroid hormone and retinoic acid. Thus seasonal changes in
HDAC4 and 6 have the potential to epigenetically modify multiple gene regulatory pathways in the
hypothalamus that could act to limit inflammatory pathways in the hypothalamus during long-day
summer-like conditions.
 2016 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
There is a growing interest in the regulation of hypothalamic
function by epigenetic mechanisms – control of gene expression
via chemical modifications of DNA or chromatin (Gali
Ramamoorthy et al., 2015). Histone deacetylases (HDACs) are
essential mediators of epigenetic regulation and act by removing
acetyl groups from lysine residues of histones, leading to chro-
matin condensation and thus transcriptional repression. The
HDACs fall into four groups, primarily based on homology to yeast
equivalent genes: class I (HDACs1, 2, 3 and 8), class IIa (HDACs 4, 5,
7 and 9), class IIb (HDACs 6 and 10), and class IV, consisting of
HDAC11 alone. Two HDACs of particular relevance to this study,
HDACs 4 and 6, have more complex functions than simply deacety-
lating histones.
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functions in both subcellular compartments (Fitzsimons, 2015). It
is associated with disorders such as 2q37-deletion syndrome
which includes facial dysmorphism, brachydactyly and obesity
with reduced expression of the RAI1 gene (Williams et al., 2010).
HDAC6 also shuttles between the nucleus and cytoplasm (Liu
et al., 2012) and it is associated with a variety of disorders from
cancer to neurodegenerative disease (Seidel et al., 2015). Several
putative functions for HDAC6 in the nucleus have been described
(reviewed by Yang and Gregoire, 2005), but HDAC6 has been
extensively investigated as an alpha-tubulin deacetylase in the
cytoplasm, regulating microtubule stability and cell motility
(Hubbert et al., 2002) during development (Creppe et al., 2009).
In neurodegenerative disease, HDAC6 may increase autophagy to
protect neurons from an accumulation of misfolded protein caused
by impairment of the ubiquitin-proteasome system (Pandey et al.,
2007). In addition, HDAC6 associates directly with ubiquitin and
the binding of HDAC6 to polyubiquitinated proteins increases
expression of cellular chaperones and protects against the harmful
effects of misfolded proteins (Boyault et al., 2007).
This study hypothesized that there would be an association
between day length (photoperiod) and HDAC gene expression
levels in the hypothalamus of animals that respond to seasonal
change. Many animals change their physiology and behavior
between seasons, recognizing the seasonal difference in day
length; the hypothalamus is the brain region in central control of
these changes (Ebling, 2015). Animal models such as the
photoperiod-sensitive F344 rat (Heideman and Sylvester, 1997)
can be used to study the shift in feeding and body weight in
response to laboratory-controlled alterations in day length. The
expression of Hdacs 1–11 was compared in F344 rats maintained
under long-day (16 h light:8 h dark) and short-day (8 h light:16 h
dark) conditions. Of the Hdacs examined, only Hdac4 and Hdac6,
and to a lesser extent Hdac9, were photoperiodically regulated in
the hypothalamus, with higher expression under long-day pho-
toperiod relative to short-day. A series of studies using inhibitors
of these HDACs suggested that one of their functions is the control
of gene expression and this has the capacity to modulate inflam-
matory and hormone (thyroid hormone and retinoic acid) signaling
pathways in the hypothalamus.
2. Materials and methods
2.1. Animals
Sprague Dawley rats were bred in the University of Aberdeen
animal facility and kept in a 12 h:12 h light:dark cycle with unlim-
ited access to food and water. Male F344/NHsd rats were supplied
by Harlan Sprague-Dawley Inc. at 5–6 weeks of age and acclima-
tized for approximately 14 days in 12 h:12 h light:dark. For pho-
toperiodic analysis of gene expression, F344 rats were randomly
divided into two weight-matched groups of 7 each and transferred
to either short day (SD; 8 h light:16 h dark) or long day (LD; 16 h
light:8 h dark) photoperiod. For in situ hybridization and qPCR,
F344 rats were anesthetized with isoflurane after 28 days in pho-
toperiod and killed by decapitation. The brains were removed,
rapidly frozen on dry ice and stored at 80C. For immunohisto-
chemistry, F344 rats were anesthetized with isoflurane after
28 days in LD photoperiod and transcardially perfused with 4%
paraformaldehyde in phosphate buffer. The brains were then
infused with 30% sucrose at 4C, frozen and stored at 80C.
F344 rats used for central thyroid-stimulating hormone (TSH)
infusions were also used for gene expression analysis reported in
another study and are fully described in Helfer et al. (2013). All
procedures conformed to Home Office regulations and local ethics
committee guidelines.2.2. Hypothalamic organotypic slice cultures
Ex vivo hypothalamic slice cultures were set up as previously
described in detail (Stoney et al., 2016b). Briefly, 400 lm-thick
coronal hypothalamic slices were prepared from P10-12 male
Sprague Dawley rat pups and maintained ex vivo on Millicell-CM
cell culture inserts (Millipore) in serum-free, vitamin A-deficient
medium consisting of Neurobasal medium containing B27 supple-
ment without vitamin A, penicillin-streptomycin and Glutamax
(all reagents from Invitrogen) and 5 mg/ml additional glucose.
Before plating out, the slices were cut in half along the midline, giv-
ing two sets of slices per animal, with each containing the same
(but alternate) regions. After 3 days in serum-free medium, slices
were treated with 10 mIU bovine thyroid-stimulating hormone
(TSH; Sigma Aldrich) dissolved in phosphate-buffered saline
(PBS). One set of slices from each animal was treated with the
other set being used as control. After 48 h of treatment, slices were
excised from the culture inserts and frozen rapidly on dry ice for
RNA extraction.
2.3. Immunohistochemistry
40 lm-thick coronal sections from F344 rat brains were cut
using a cryostat. Sections containing the hypothalamus were used
for immunohistochemistry as previously described (Shearer et al.,
2012a; Stoney et al., 2016a). Sections were labelled with antibodies
against HDAC4 (ab79521, Abcam), MAP2 (ab5392, Abcam), GFAP
(G3893, Sigma-Aldrich), Iba1 (ab5076, Abcam) and vimentin
(V6389, Sigma-Aldrich).
2.4. Cell culture
Primary tanycyte cultures were prepared from 10-day-old male
Sprague Dawley rat pups as previously described (Bolborea et al.,
2015; De Seranno et al., 2004; Prevot et al., 2003). Briefly, brains
were removed under sterile conditions, placed in ice-cold DMEM/
F-12 medium containing penicillin/streptomycin and 25 mM
HEPES and the median eminence dissected. Median eminences
from 8–10 pups were pooled together, dissociated with trypsin
and plated out in DMEM/F-12 containing 10% fetal calf serum and
penicillin/streptomycin in a 25 cm2 cell culture flask. The medium
was replaced every 2–3 days and the cells transferred to 12-well
plates for experiments after 8–10 days in vitro. The day after plating
out, tanycytes were treated with vehicle or HDAC inhibitor (Tubas-
tatin A at 5 lM or LMK235 at 1 lM) for 1 h and then LPS at 1 lg/ml
for 3 h. RNA was extracted from treated cells for qPCR analysis.
The cell line GT1-7 (Mellon et al., 1990) is a widely used
hypothalamic cell line used in over 400 published papers. GT1-7
cells were maintained in Dulbecco’s modified eagle medium with
10% fetal bovine serum. To examine the influence of HDACs on
TNFa function the cells were treated with vehicle or HDAC inhibi-
tor (Tubastatin A at 5 lM or LMK235 at 1 lM) for 1 h and then
TNFa at 1 ng/mL for 3 h. Alternatively, to investigate the influence
of HDACs on retinoic acid or T3 function, the cells were treated
with retinoic acid (1 lM) or T3 (50 nM) in addition to an HDAC
inhibitor (Tubastatin A at 5 lM or LMK235 at 1 lM) or vehicle
for 24 h. In both cases RNA was extracted from treated cells for
qPCR analysis.
2.5. Immunocytochemistry
Primary tanycytes and GT1-7 cells were plated onto polylysine-
coated glass coverslips. The following day, the cells were fixed and
immunolabelled as previously described (Shearer et al., 2012a)
using antibodies against HDAC4 (as above), HDAC6 (ab1440,
Abcam) and NeuN (MAB377, Chemicon).
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Hypothalamic blocks encompassing the mediobasal hypothala-
mus were dissected from F344 brains whilst frozen and total RNA
was extracted using a Qiagen RNeasy RNA purification kit. RNA
was isolated from cultured hypothalamic slices using the same
kit. cDNA was synthesized from 500 ng total RNA using High
Capacity RNA-to-cDNA Master Mix (Applied Biosystems Ltd). Pri-
mers were designed using PrimerBLAST (Ye et al., 2012; Table 1),
apart from Dio2 and Dio3 primers, which were obtained from Qia-
gen (QuantiTect Primer Assays Rn_Dio2_2_SG and Rn_Dio3_1_SG,
respectively). qPCR reactions were set up using SensiMix SYBR
master mix (Bioline) and were run on a Roche LightCycler 480
and analyzed using LightCycler 480 1.5 software. Expression of
genes of interest was normalized to Actb levels. Standard curves
and blank controls were run for all sets of primers. Differences in
gene expression were assessed by Student’s t-test or ANOVA as
appropriate.
2.7. In situ hybridization
In situ hybridization was performed as described in detail in
(Ross et al., 2009). A riboprobe template for Hdac4 was amplified
by PCR from rat hypothalamic cDNA using forward 50-CAG CCC
TCC AGC AGC GAA TCT CC-30 and reverse 50-TCT GTC TCC TCC
GGG TGG CTC TCA-30 primers and cloned into pCR4 Blunt TOPO
vector (Invitrogen). For Nfkb1 an EST clone was purchased from
Source BioSciences (IMAGE ID: 7366143). 35S-labelled antisense
riboprobes were generated from 150–200 ng template DNA by T7
polymerase. Slides were apposed to Biomax MR Film (Kodak) for
7 days, scanned at 1200 dpi and analyzed using Image-Pro Ana-
lyzer (Media Cybernetics UK).
2.8. Western blotting analysis
Cells for analysis were washed with cold PBS and lysed with cell
lysis buffer (150 mM NaCl, 1% Triton, 0.1% SDS, 50 mM HEPES)
containing protease inhibitor cocktail (Sigma). Protein concentra-
tions were measured using a BCA assay kit (ThermoFisher
Scientific). 50 lg protein was loaded and separated on 12%
SDS-polyacrylamide gels and then transferred to nitrocellulose
membranes. The membranes were blocked with 5% milk in
Tris-buffered saline containing 0.05% Tween-20 (TBST) for 1 h at
room temperature. The blots were incubated overnight in primary
antibody at 4C diluted in TBST containing 2% BSA. The following
day, the blots were washed three times with TBST before incubat-
ing with horseradish peroxidase-conjugated antibody (Jackson
Immunoresearch) diluted in TBST containing 5% milk for 1 h at
room temperature. Finally, after 3 washes in TBST, the blots were
developed using enhanced chemiluminescence (Millipore) and
the protein bands were detected and scanned using a myECL
Imager (ThermoScientific). Afterwards, band intensities were
quantified from images using ImageJ software. Antibodies used
were against: a-tubulin (T6074, Sigma), acetylated a-tubulin
(Lys40, 5335, NEB), NF-jB (Cell Signaling, 4764), and phospho-
NF-jB p65 (Ser536, Cell Signaling, 3033).3. Results
3.1. Hdac gene expression in the rat hypothalamus switches between
seasons
The seasonal changes in animals that influence behaviors such
as appetite and reproduction are regulated by the hypothalamus
using a variety of signaling routes that regulate gene expression.Nuclear receptor family members are important mediators of such
signaling pathways (Ebling, 2014, 2015) and HDACs, by controlling
the open or closed state of chromatin, can have a profound influ-
ence on their action. The expression of HDACs 1–11 was investi-
gated in animals kept for 28 days under long-day (LD, 16 h:8 h
light:dark) or short-day (SD, 8 h:16 h light:dark) conditions.
As positive controls for a response to the change in light dura-
tion, we measured the expression of Dio2 and Dio3, which encode
the deiodinase enzymes that respectively activate (Dio2) or inacti-
vate (Dio3) thyroid hormone. Consistent with previous studies
were the reciprocal changes in Dio2 and Dio3 expression following
a LD to SD switch (Helfer et al., 2013; Watanabe et al., 2004, 2007),
although only the change in Dio3was statistically significant in the
current study (p = 0.013; Fig. 1A). As further controls for the known
LD increase in thyroid hormone (Dardente et al., 2014) and retinoic
acid signaling (Shearer et al., 2012b), expression of Nrgn, a gene
with a well-characterized thyroid hormone response element
(Martinez de Arrieta et al., 1999) and Rarb, with a well-
characterized retinoic acid response element (de Thé et al., 1990)
were quantified. No significant change in Nrgn was evident
(Fig. 1B) but the rise in retinoic acid signaling was sufficient to
induce Rarb but not family members Rara or Rarg (Fig. 1B). Of
the HDACs, only Hdac4, 6 and 9 showed significant differences in
expression between LD and SD photoperiod (p = 0.035, p = 0.001,
p = 0.022, respectively; Fig. 1C). Focusing on the HDACwith the lar-
gest change in expression by qPCR, the distribution of Hdac4 was
examined by in situ hybridization after 28 days in LD photoperiod.
Strong expression was evident in the ependymal layer lining the
third ventricle (Fig. 1D), a region that includes tanycytes, known
to be important regulators of appetite and energy balance in the
hypothalamus (Bolborea and Dale, 2013). Lower expression of
Hdac4 was also apparent in the parenchyma of the hypothalamus
(Fig. 1D). Quantifying expression in the lining of the third ventricle,
the expression of Hdac4 was approximately 5-fold higher in LD
compared to SD (p < 0.001; Fig. 1E). This suggests that, although
qPCR analysis of the entire hypothalamus provides a useful method
for screening (Fig. 1C), it underestimates the changes in expression
between photoperiod in local regions where expression changes
are large.
Thyroid-stimulating hormone (TSH) acts as an essential inter-
mediary in the control of seasonal changes in the hypothalamus
and drives photoperiodic changes in gene expression (Dardente
et al., 2014). To determine whether TSH may be a trigger to induce
Hdac4 expression, animals were maintained under SD conditions
when Hdac4 expression is at its lowest and TSH or vehicle was
infused into the third ventricle. Fourteen days of central TSH infu-
sion (1.0 mIU/day) resulted in a significant increase in Hdac4
expression (p = 0.035; Fig 2A) although this did not reach the same
level of expression seen under LD conditions. To confirm that TSH
could act directly on the hypothalamus to induce Hdac4 expres-
sion, organotypic slice cultures of the hypothalamus were treated
with 10 mIU of TSH. It was confirmed that TSH in this system sig-
nificantly induced Dio2 (Shinomiya et al., 2014) (p = 0.015, Fig 2B),
while the expected decline in Dio3was reported previously (Stoney
et al., 2016b). As was already demonstrated in vivo, TSH also signif-
icantly induced Hdac4 expression in organotypic hypothalamic
slice cultures (p = 0.023; Fig. 2C). In contrast, Hdac6 was not
induced by TSH (Fig. 2D).
3.2. HDAC4 and 6 are strongly expressed in the nucleus
The focus on the possible functions of HDACs in the hypothala-
mus was directed towards Hdac4 and Hdac6, which showed the
largest significant changes between photoperiods. The primary
drive behind this study was to investigate HDACs as regulators of
gene expression; however, both HDAC4 and 6 have major
Fig. 1. Comparison between short-day versus long-day photoperiod reveals changes in Hdac gene expression in the hypothalamus. (A) As positive controls, hypothalamic
expression of Dio2 increased and Dio3 decreased in long-day conditions relative to short-day. (B) A reporter of thyroid hormone signaling (Nrgn) did not change between
short- and long-day while a reporter of retinoic acid signaling (Rarb) significantly increased in long-day conditions but no such change was seen for other members of the RAR
family, Rara or Rarg. (C) Three HDAC genes, Hdac4, 6 and 9 showed significantly higher expression in long-day photoperiod, although the change in Hdac9was small. (D) In situ
hybridization verified the increase in expression of Hdac4 predominantly in the ependymal layer around the third ventricle (3V). (E) Quantification of in situ hybridization in
the ependymal layer shows a significant five-fold increase in Hdac4 expression in long-day photoperiod. qPCR quantification of gene expression is shown relative to Actb
levels. ⁄p < 0.05, ⁄⁄⁄p < 0.001.
P.N. Stoney et al. / Brain, Behavior, and Immunity 61 (2017) 340–352 343functions in the cytoplasm (Fitzsimons, 2015; Seidel et al., 2015).
Nevertheless, several studies have suggested that they can act as
conventional HDACs and regulate gene expression and this is
dependent on their presence in the nucleus (Fitzsimons, 2015;Seidel et al., 2015). Nuclear versus cytoplasmic distribution of the
HDACs was examined by immunocytochemistry in primary cul-
tured tanycytes, TSH-responsive cells lining the third ventricle in
which the Hdac4 transcript was present (Fig. 1D), and the GT1-7
Fig. 2. Regulation of Hdac4 expression in the hypothalamus by thyroid-stimulating hormone (TSH) . (A) Infusion of TSH into the third ventricle of the short-day rat induced
Hdac4 expression and so partially mimicked the effect of long-day conditions. (B) The direct effect of TSH on the hypothalamus could be demonstrated by the addition of TSH
to hypothalamic organotypic slice cultures which induced Dio2 as a positive control. (C) Hdac4 also responded to TSH in hypothalamic organotypic slice cultures whereas (D)
Hdac6 did not. qPCR quantification of gene expression is shown relative to Actb levels. ⁄p < 0.05, ⁄⁄⁄p < 0.001.
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both cell types, the distribution of HDAC4 was primarily
nuclear, while HDAC6 was present in the nucleus and cytoplasm
(Fig. 3A–D). Thus both HDAC4 and 6 have the capability to
influence nuclear processes in these cell types. To determine the
distribution of HDACs in the hypothalamus, immunohistochem-
istry was performed on brain sections from F344 rats kept on LD
photoperiod for 28 days. Only the antibody against HDAC4 showed
specific staining under these conditions and HDAC4 was predomi-
nantly found in the nucleus (Fig. 3E–H). To determine the cell types
expressing HDAC4, rat brain sections were double-labelled with
antibodies against HDAC4 and the cell type-specific markers
MAP2 for neurons, vimentin for tanycytes, GFAP for astrocytes,
and Iba1 to label microglia. HDAC4 was present in both neurons
and the ependymal cell lining of the third ventricle, which includes
tanycytes (Fig. 3E and F) but was absent from microglia and glia
(Fig. 3G and H). Expression of HDAC4 was compared between brain
sections from six rats after 28 days in either SD or LD photoperiod
and Fig. 4A–F shows images of the ventral hypothalamus in the
region of the arcuate nucleus. HDAC4 expression in both SD
(Fig. 4A, C, E) and LD (Fig. 4B, D, F) was observed in the ependymal
cell layer as well as the parenchyma of the hypothalamus. Despite
considerable variation in HDAC4 expression in the ependymal
layer of different rats, there were no major changes in nuclear ver-
sus cytoplasmic HDAC4 expression in this region (Fig. 4A1 and B1).
However, expression of HDAC4 appeared stronger in LD compared
to SD conditions while expression of another protein, NeuN, which
like HDAC4 is predominantly present in the nucleus and weaklypresent in the cytoplasm (Lind et al., 2005), showed similar expres-
sion in hypothalami between LD and SD conditions (Fig. 4G and H).
3.3. Nfkb1 is an inflammatory-mediating gene in the hypothalamus
that switches in expression between seasons
Due to their nuclear localization, we next explored the potential
for HDAC4 and 6 to modulate pathways controlling gene expres-
sion. Previous studies of the role of HDACs in cell proliferation
(Mottamal et al., 2015) have pointed to a central mechanism of
HDAC action through the nuclear transcription factor nuclear fac-
tor kappa-light-chain-enhancer of activated B cells (NF-jB;
(Glozak and Seto, 2007)). Therefore, the effect of photoperiod on
NF-jB signaling was investigated. In situ hybridization showed
that Nfkb1 gene expression is significantly altered in the hypotha-
lamus with photoperiod showing the reverse pattern to the HDACs
with lower levels under LD versus SD photoperiod conditions
(p = 0.003; Fig. 5A and B). Its expression is predominantly in the
ependymal lining of the third ventricle of the hypothalamus, sim-
ilar to that of Hdac4.
3.4. Inhibition of HDACs modifies gene expression induced by NF-jB
activators
To study the potential influence of HDACs on NF-jB signaling,
the pathway was activated in the presence of HDAC inhibitors. This
was explored in cultured primary hypothalamic tanycytes and the
well-characterized GT1-7 hypothalamic neuronal cell line. To
Fig. 3. Immunohistochemistry of HDAC4 and HDAC6 in hypothalamic cells shows their expression in the nucleus. (A) HDAC4 in cultured tanycytes and (C) the hypothalamic
neuronal GT1-7 cell line showed that it is present only in the nucleus. HDAC6 was localized to the nucleus of cultured tanycytes (B) and GT1-7 cells (D) but was also present at
lower levels in the cytoplasm. (E-H) Double-labelling of rat brain sections, with nuclei stained blue with bisbenzamide, anti-HDAC4 in red and antibodies to the following
markers in green: (E) MAP2 for neurons with two double-labelled cells highlighted with white arrows (F), vimentin for tanycytes with two double-labelled cells highlighted
with white arrows, (G) GFAP for astrocytes and (H) Iba1 to label microglia. This illustrated that HDAC4 is present in both neurons and tanycytes but absent frommicroglia and
glia. Scale bars = 25 lm.
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treated with the HDAC6-specific inhibitor Tubastatin A (Butler
et al., 2010). There is no specific inhibitor for HDAC4 and therefore
LMK235 was employed which inhibits the class IIa HDACs 4 and 5,
and weakly the class IIb HDAC6 (Marek et al., 2013). To confirm
that LMK235 had little cross-over in inhibiting HDAC6 at the
1 lM concentration used in these studies, GT1-7 cells were treated
with this concentration of LMK235 and the activity of HDAC6 to
deacetylate tubulin was quantified by western blotting. Acetylated
a–tubulin was almost undetectable in LMK235-treated GT1-7 cells
(Fig. 6 right). In contrast, GT1-7 cells treated with 5 lM Tubastatin
A greatly increased the amount of acetylated a–tubulin by inhibit-
ing its deacetylation (Fig. 6 left).
To determine the best activator of NF-jB signaling in GT1-7
cells, a comparison was made between tumour necrosis factor
alpha (TNFa) and lipopolysaccharide (LPS). Levels of phosphory-
lated NF-jB were measured in GT1-7 cells following incubation
with TNFa or LPS for 30 minutes, 1 hour or 3 hours
(Fig. 7A and B). TNFa induced the greatest increase in NF-jB
phosphorylation in GT1-7 cells and hence the effect of HDAC
inhibition on rapid induction of gene expression by TNFa (3 h)
was investigated. Fos, an immediate early gene which encodesone of the components of the activator protein-1 (AP-1) transcrip-
tion factor, has been described to be regulated by TNFa (Fujioka
et al., 2004), but TNFa alone did not induce Fos in GT1-7 cells
(Fig. 7C). However, inhibition of HDAC4/5 using LMK235 resulted
in significant induction of Fos by TNFa. Inhibition of HDAC6 by
Tubastatin A had a similar effect to allow induction of Fos by TNFa
(Fig. 7C, left and right). Prkca, which encodes protein kinase C
alpha, was not induced by TNFa with or without HDAC4/5 inhibi-
tion (LMK235) while it was slightly but significantly increased by
HDAC6 inhibition (Tubastatin A, Fig. 7D, right). Prkcd (protein
kinase C delta) was not induced by TNFa but both of the HDAC
inhibitors, by themselves, induced Prkcd (Fig. 7E, left and right).
Finally, Ptp1b, a phosphatase acting on the insulin receptor regu-
lated by TNFa via NF-jB in adipose tissue (Zabolotny et al.,
2008) and NF-jB in the hypothalamus (Garcia-San Frutos et al.,
2012) was investigated. TNFa significantly increased the capacity
of HDAC 4/5 inhibitor LMK235 (weakly, Fig. 7F, left) and HDAC6
inhibitor Tubastatin A (to a greater extent, Fig. 7F, right) to induce
Ptp1b.
Tanycytes, a second hypothalamic cell type in which HDACs
could function, were also investigated. To determine the best acti-
vator of NF-jB signaling in these cells, cultured tanycytes were
Fig. 4. Expression of HDAC4 in ventral hypothalamus in long-day compared to
short-day conditions. HDAC4 was expressed in both the ependymal cell layer
(white arrow A and B) and the parenchyma in the hypothalamus of six rats kept in
either (A, C, E) short-day or (B, D, F) long-day conditions. Variation in expression in
the ependymal layer was quite high but HDAC4 was clearly present in nuclei, and
more weakly in cytoplasm, in some ependymal cells in both (A1) short-day and (B1)
long-day conditions, shown at higher magnification. Expression of HDAC4 though
was generally stronger in long-day compared to short-day conditions while
expression of (G and H) NeuN was similar in both conditions. Scale bars = 20 lm
in A-F, 40 lm in G and H and 12 lm in A1 and B1.
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phosphorylated NF-jB was quantified (Fig. 8A and B). LPS induced
a much greater increase in NF-jB phosphorylation in tanycytes
than TNFa and therefore we investigated the effect of HDAC inhi-
bition on rapid induction of gene expression by LPS in tanycytes.
Fos was weakly repressed by LPS (Fig. 8C) while HDAC4/5 inhibi-
tion (LMK235) with or without LPS led to a greater reduction in
TNFa (Fig. 8C, left). In contrast, the HDAC6 inhibitor (Tubastatin
A) turned LPS into a significant inducer of Fos (Fig. 8C, right). Nei-
ther the HDAC4/5 nor the HDAC6 inhibitor had a significant effect
on LPS induction of Prkca (Fig. 8D). However HDAC4/5 inhibition
with LMK235 resulted in a significant increase in LPS induction
of Prkcd expression (Fig. 8E, left). Ptp1b, in contrast, was unaffected
by LPS with or without HDAC4/5 inhibition by LMK235 (Fig. 8F,
left). However, the HDAC6 inhibitor (Tubastatin A) by itself or with
LPS significantly induced Ptp1b expression (Fig. 8F, right).3.5. Inhibition of HDACs modifies gene expression induced by nuclear
receptor activators
The activity of nuclear receptors is strongly influenced by the
level of chromatin condensation, regulated by the acetylation state
of histones (McKenna et al., 1999) and this is the case for both the
retinoic acid receptor (RAR) and thyroid hormone receptor (THR)
(Xu et al., 1999). A seasonal change in HDAC expression would
be important for both these nuclear receptors because both RAR
and THR mediate signals controlling energy balance and growth
in the hypothalamus (Ebling, 2015) while RAR also acts to suppress
inflammatory pathways (Kim et al., 2013; van Neerven et al.,
2010). Therefore, the effects of the HDAC4/5 inhibitor LMK235
and HDAC6 inhibitor Tubastatin A on the ability of the nuclear
receptors RAR and THR to increase transcription in GT1-7 cells
was investigated. We assessed the effects of LMK235 and Tubas-
tatin A on expression of Rarb and Nrgn, genes with well-
characterized response elements for RAR (de Thé et al., 1990)
and THR (Martinez de Arrieta et al., 1999) respectively, which we
had investigated for photoperiodic change (Fig. 1B). After 3 h treat-
ment with retinoic acid the HDAC4/5 inhibitor (LMK235) did not
significantly influence the induction of Rarb by retinoic acid
(Fig. 9A), however HDAC6 inhibition (Tubastatin A) led to an
increase in the potency of retinoic acid action on this gene
(Fig. 9B). Rarb was unresponsive to T3, the bioactive form of thy-
roid hormone, with or without either of the HDAC inhibitors
(Fig. 9A and B). Investigating the effects of T3 on Nrgn, both
HDAC4/5 and HDAC6 inhibitors significantly increased induction
by T3 (Fig. 9C and D). Both inhibitors also resulted in a significant
increase in the background expression of Nrgn (Fig. 9C and D). Reti-
noic acid had no significant effect on the expression of Nrgn, either
in the presence or absence of the HDAC inhibitors (Fig. 9C and D).4. Discussion
The photoperiodic F344 rat provides a unique rat model to
study hypothalamic regulation of appetite and energy homeostasis
using a natural environmental switch to force a homeostatic
change rather than more extreme manipulations, such as high-fat
diet. This study focused on possible epigenetic changes that may
be part of this seasonal switch, examining alterations in gene
expression of HDACs, which deacetylate histones, promoting chro-
matin condensation and thus suppressing gene expression. Sea-
sonal epigenetic changes have been shown in the immune
system (Stevenson et al., 2014) and epigenetic alterations in the
brain can have profound effects on behavior (Mathews and
Janusek, 2011). Three members of the HDAC family, Hdac4, 6 and
9, were found to be under photoperiodic control and were
expressed at higher levels under long-day (summer-like) versus
short-day (winter-like) conditions. For Hdac4, these changes in
mRNA expression were evident in the ependymal cells and tany-
cytes lining the third ventricle and when measured specifically in
these cells, the change in gene expression was large (5-fold). TSH
was shown to induce Hdac4 expression both in vivo and ex vivo
and therefore TSH is likely to act as an intermediary by which
melatonin may trigger seasonal changes in Hdac4 expression, as
is the case for a number of other genes which are key intermedi-
aries in melatonin’s control of seasonal change in the hypothala-
mus (Dardente et al., 2014). In contrast, Hdac6 was not inducible
by TSH in the hypothalamus and its seasonal change is presumably
mediated by alternative factors.
To study the potential functions of these HDACs, chemical
inhibitors were used on cultured primary hypothalamic tanycytes
and a representative hypothalamic neuronal cell line, GT1-7. Given
the primarily nuclear location of these HDACs, nuclear signaling
Fig. 5. Seasonal change in daylength results in altered expression of the nuclear factor Nfkb1 transcript. (A) In situ hybridization showed a decrease in Nfkb1 expression in the
cells lining the third ventricle of the hypothalamus with change in photoperiod from short- to long-day. (B) Quantification of this change indicated significantly lower
expression in long-day photoperiod relative to short-day. qPCR quantification of gene expression is shown relative to Actb levels. ⁄⁄p < 0.01.
Fig. 6. The HDAC4/5 inhibitor LMK235 shows little inhibition of HDAC6 in GT1-7
cells. Cells were treated with 1 lM LMK235 and its effects on inhibition of HDAC6
were determined by measuring deacetylation of a-tubulin by western blotting. The
LMK235-treated cells had relatively little acetylated a-tubulin, shown as a ratio of
acetylated a-tubulin/total a-tubulin, whereas the HDAC6 inhibitor Tubastatin A
(5 lM) significantly increased the amount of acetylated a-tubulin by inhibiting its
deacetylation (⁄p < 0.05).
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particular interest given the change in Nfkb1 gene expression
between seasons; this is the second inflammatory mediator shown
to change its expression with photoperiod, the other being che-
merin (Helfer et al., 2016). The concept that the hypothalamus in
photoperiodic animals may respond differently to inflammatory
signals depending on day length was proposed several years ago
(Fonken et al., 2012). The use of HDAC inhibitors, one primarily act-
ing on HDAC4/5 and another specific for HDAC6, suggested that
these HDACs act to reduce the capacity of the factors that signal
via NF-jB, TNFa- and LPS-activated pathways, to regulate genes
acting on several pathways including AP-1 (Fos), protein kinase C
and the protein-tyrosine phosphatase Ptp1b. The decrease in
Hdac4, 6 and 9 during short-day photoperiod, and presumed
decline in their corresponding protein, will increase the capacityof NF-jB to induce genes such as Fos, Prkca and Ptp1b. This coin-
cides with the increase in Nfkb1 under the same short-day condi-
tions and the combination of decreased Hdac expression and
increased NF-jB may potentiate the ability of this inflammatory
signal to regulate gene expression during short-day photoperiod.
TNFa and LPS are proinflammatory molecules and the concept
that the HDACs are involved in inflammatory processes has been
previously suggested by the requirement for HDAC4 in efficient
inflammatory cytokine production activated by LPS (Wang et al.,
2014). Prolonged LPS treatment leads to HDAC4 degradation via
caspase 3 (Wang et al., 2014). In macrophages, HDAC4, when acti-
vated by cAMP, shuttles to the nucleus where it inhibits NF-jB
activity on proinflammatory genes (Luan et al., 2014). In adipose
tissue, in which inflammation is proposed to be part of the trigger
for obesity, HDAC4 is known to inhibit NF-jB activity in the
nucleus (Abu-Farha et al., 2013; Luan et al., 2014). Further suggest-
ing the existence of inflammatory signaling pathways in the
hypothalamus, LPS-induced inflammation in hypothalamic tany-
cytes leads to an increase in the capacity of thyroid hormone to
induce Dio2 via an NF-jB mediated pathway (Fekete et al., 2004).
Both HDAC4 and 6 shuttle between the nucleus and cytoplasm,
but much attention has been directed towards their function in the
cytoplasm. HDAC6 deacetylates several cytoplasmic proteins
including tubulin and HSP90 (Yang et al., 2013) while there is
the suggestion that HDAC4 may not function as a lysine deacety-
lase (Mielcarek et al., 2013). However, both HDAC4 and HDAC6
can be found in the nucleus under some circumstances
(Fitzsimons, 2015; Liu et al., 2012) and the results of our immuno-
histochemistry support this. HDAC4 can repress transcription
(Wang et al., 1999) and may recruit other histone deacetylases in
this action (Chan et al., 2003; Zhang et al., 2002).
This repressive action of HDACs on gene expression can have a
strong effect on nuclear receptor-induced transcription and our
studies pointed to such a repressive action of HDACs on target
genes of the nuclear receptors RAR and THR. Both thyroid hormone
(Dardente et al., 2014) and retinoic acid (Shearer et al., 2012b) act
to regulate gene expression during LD photoperiod and a simulta-
neous increase in HDAC in LD conditions will have a limiting effect
on these signaling pathways. This repressive action of HDACs has
been proposed, for instance, in HDAC4’s association with reduced
binding of THR to the thyroid hormone response element (TRE)
of Glut4 (Raychaudhuri et al., 2014). Movement of HDAC4 between
cytoplasm and nucleus is controlled by its phosphorylation
(Fitzsimons, 2015). In the case of HDAC6, it is acetylation that
Fig. 7. The effect of HDAC inhibitors on NF-jB target gene activation by TNFa in GT1-7 cells. Activation of NF-jB by TNFa (1 ng/mL; A) and LPS (1 lg/mL; B) was compared by
western blotting of phosphorylated NF-jB, after 30 min, 1 h and 3 h treatment with the ratio between phosphorylated NF-jB and total NF-jB graphed normalized relative to
controls. TNFa showed the greater induction and so the influence of HDAC inhibitors was tested on TNFa induced gene expression. The effect of HDAC4/5 inhibition by
LMK235 and HDAC6 inhibition by Tubastatin A was investigated on TNFa-induced expression of (C) Fos (D) Prkca (E), Prkcd and (F) Ptp1b. qPCR quantification of gene
expression is shown relative to Actb levels. ⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001.
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2012). HDAC6 can be acetylated by the nuclear co-activator and
acetyltransferase, p300 (Han et al., 2009). Reciprocally, it has been
proposed that HDAC6 acts to modulate p300-dependent transcrip-
tion by binding to sumoylated p300 (Girdwood et al., 2003).
HDAC6 may also be involved in repression of p21 expression by
Runx2 (Westendorf et al., 2002) and the repressive action of NF-
jB on particular genes (Zhang and Kone, 2002). HDAC6 has been
found to be associated with other nuclear receptors including thevitamin D receptor (Toropainen et al., 2010). HDAC6 is also a
nuclear cofactor for ligand-dependent corepressor (LCoR) in its
suppression of estrogen-induced transcription (Palijan et al., 2009).
The importance of epigenetic control of hypothalamic gene
regulation has been increasingly recognized. For instance, the
hypothalamic response to dietary change, whether fasting or
high-fat diet, includes a change in the pattern of Hdac expression
(Funato et al., 2011). Changes in the environment of a mother
can result in long-term behavioral changes in her offspring via
Fig. 8. The effect of HDAC inhibitors on NF-jB target gene activation by LPS in tanycytes. Activation of NF-jB by TNFa (1 ng/mL; A) and LPS (1 lg/mL; B) was compared by
western blotting of phosphorylated NF-jB, after 30 min, 1 h and 3 h treatment with the ratio between phosphorylated NF-jB and total NF-jB graphed normalized relative to
controls. In tanycytes, LPS induced much greater phosphorylation than TNFa and so the influence of HDAC inhibitors was tested on LPS-induced gene expression in tanycytes.
The effect of HDAC4/5 inhibition by LMK235 and HDAC6 inhibition by Tubastatin A was investigated on LPS-induced expression of (A) Fos (B) Prkca (C), Prkcd and (D) Ptp1b.
qPCR quantification of gene expression is shown relative to Actb levels. ⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001.
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Ramamoorthy et al., 2015), while HDACs help guide the sexual dif-
ferentiation of the hypothalamus during development of the brain
(Matsuda et al., 2012). Our findings of a switch in Hdac expression
driven by a change in photoperiod may not be unexpected and part
of the mechanism involved in the seasonal switch in control of
physiology and behavior.
Our results suggest that increased HDAC4 and 6 during LD
(summer-like) conditions will limit the capacity of inflammatory
factors acting through NF-jB to induce gene expression, as wellas decrease the ability of thyroid hormone and retinoic acid to
induce gene expression. This occurs at a time when NF-jB is also
falling, but when other factors are on the rise; during LD there is
an increase in the inflammatory factor chemerin (Helfer et al.,
2016) and both thyroid hormone (Ross et al., 2011) and retinoic
acid (Helfer et al., 2012). This indicates that inflammation as a gen-
eral phenomenon does not simply rise and fall between SD and LD
but, as may be expected, different elements of the inflammatory
pathway are used as molecular steps in both SD and LD. As such,
a general induction of inflammation in the hypothalamus, for
Fig. 9. The effect of HDAC inhibitors on nuclear receptor-activated gene expression. The influence of inhibition of (A) HDAC4/5 by LMK235 or (B) HDAC6 by Tubastatin A on
induction of Rarb by retinoic acid. The influence of inhibition of (C) HDAC4/5 by LMK235 or (D) HDAC6 by Tubastatin A on induction of Nrgn by thyroid hormone. qPCR
quantification of gene expression is shown relative to Actb levels. ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001. Tub A, Tubastatin A; RA, retinoic acid; T3, thyroid hormone.
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photoperiodic switch but would have aspects of both SD and LD in
cell signaling and perhaps physiology. It would also be predicted
that photoperiod will influence the impact of inflammation on
hypothalamic function, and these ideas will be intriguing to test
in the future. The inhibitory action of HDAC4 and 6 during LD when
thyroid hormone and retinoic acid signaling increase suggest that
there are subsets of genes in particular hypothalamic regions, or
times during LD, in which the action of these nuclear receptor
ligands require inhibition. The next stage of investigation into
the photoperiodic switch in HDAC expression will explore this.
Something similar is seen during LD for retinoic acid in which there
is a large increase in the retinoic acid catabolic enzyme Cyp26b1
during LD conditions (Helfer et al., 2012) which would oppose
the simultaneous increase in retinoic acid signaling (Shearer
et al., 2010). A limitation of the study to note is that the mechanis-
tic study of HDAC function is performed in vitro rather than in vivo
and future studies of Hdac4 and Hdac6 knockouts will be valuable
when performed in photoperiodic animals, which is now achiev-
able through CRISPR-Cas9-based approaches.
The types of systems we have shown to be controlled by HDACs
in the hypothalamus, NF-jB-mediated inflammatory pathways,
and activation of gene expression by thyroid hormone and retinoic
acid, have been described to change in multiple animals that pho-
toperiodically switch in their physiology (Ebling, 2015; Helfer
et al., 2016). A change in hypothalamic HDAC expression would
be of great interest to study in these species. A question arises
whether similar alterations might occur in the human hypothala-
mus, the question hinging on whether human physiology has a
seasonally-driven rhythm. Studies have derived varied conclusions(Foster and Kreitzman, 2010). Disease susceptibility (Stevenson
et al., 2015), immune function and metabolic disease (Dopico
et al., 2015; Goldinger et al., 2015), as well as psychiatric disease
and seasonal affective disorder (Magnusson and Boivin, 2003;
Qin et al., 2015) have all been shown to change with season. The
system that controls photoperiodism i.e. the night time rise in
melatonin, is known to function in humans. Further, seasonal
changes in the morphology of the human hypothalamus have been
reported (Hofman and Swaab, 1992). Thus the control system we
describe in the rat may be relevant to parallel regulatory systems
in the human hypothalamus.
Our results point to a potential role for HDACs in both inflam-
matory signaling (via NF-jB) and hormonal (thyroid hormone
and retinoic acid) pathways known to act in the hypothalamus
(Purkayastha and Cai, 2013; Valdearcos et al., 2015) and HDAC4
and 6 may sit at a nexus linking epigenetic modulation of hormone
and inflammatory pathways in the hypothalamus. NF-jB is
described as a pro-inflammatory master switch determining pro-
duction of various inflammatory mediators, triggering hypothala-
mic inflammation that can lead to altered hypothalamic control
of metabolism to result in metabolic syndrome (Purkayastha
et al., 2011; Zhang et al., 2008). Thyroid hormone has control over
many hypothalamic roles from appetite to reproductive function
(Lechan and Fekete, 2005) while retinoic acid is likely to supple-
ment the function of thyroid hormone (Stoney et al., 2016b) as well
as controlling cell behavior such as hypothalamic neurogenesis
(Shearer et al., 2012c). HDAC expression is an epigenetic switch
that can cascade onto these many pathways through repression
of NF-jB, thyroid hormone and retinoic acid control of hypothala-
mic gene expression.
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